796.9500 -34.90 (-4.20%)
NSE Oct 08, 2025 15:31 PM
Volume: 353.1K
 

796.95
-4.20%
Sharekhan
Q2FY2021 was a soft quarter for Strides. The results missed estimates. Revenues grew 11% YoY to Rs 793 crore while the adjusted PAT at Rs 44 crore declined by 9%. Strtides expects a marked improvement in its performance in 2HFY2021 as compared...
Strides Pharma Science Ltd. has lost -43.49% in the last 1 Year
More from Strides Pharma Science Ltd.
Recommended